NewAmsterdam Pharma Co N.V. (NAMS): SCHEDULE 13G/A filed May 6, 2026

Form type

SCHEDULE 13G/A

Filing date

May 6, 2026

Accession number

0000315066-26-001273

Filer

NewAmsterdam Pharma Co N.V. (CIK 1936258)